Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Operating Leases (2023 - 2025)

Historic Operating Leases for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $36.1 million.

  • Metagenomi's Operating Leases fell 1277.28% to $36.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year decrease of 1277.28%. This contributed to the annual value of $40.2 million for FY2024, which is 1030.31% down from last year.
  • Latest data reveals that Metagenomi reported Operating Leases of $36.1 million as of Q3 2025, which was down 1277.28% from $37.5 million recorded in Q2 2025.
  • Metagenomi's 5-year Operating Leases high stood at $44.8 million for Q4 2023, and its period low was $36.1 million during Q3 2025.
  • In the last 3 years, Metagenomi's Operating Leases had a median value of $40.8 million in 2024 and averaged $40.6 million.
  • Its Operating Leases has fluctuated over the past 5 years, first crashed by 1030.31% in 2024, then plummeted by 1277.28% in 2025.
  • Over the past 3 years, Metagenomi's Operating Leases (Quarter) stood at $44.8 million in 2023, then dropped by 10.3% to $40.2 million in 2024, then dropped by 10.19% to $36.1 million in 2025.
  • Its Operating Leases was $36.1 million in Q3 2025, compared to $37.5 million in Q2 2025 and $38.8 million in Q1 2025.